CAMBRIDGE, Mass.–(BUSINESS WIRE)– Paragonix Technologies Inc.today announced clearance of a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration (FDA) for its Donor Lung Preservation System – LUNGguard1,2. The Paragonix LUNGguard Donor Lung Preservation System is intended to be used for the static hypothermic preservation of lungs during transportation and
Paragonix Technologies, Inc., Announces First Successful Use of Paragonix SherpaPak™ Cardiac Transport System in Pediatric Transplant Recipients
Paragonix Technologies, Inc. today announced that the first series of pediatric donor hearts preserved and transported using Paragonix SherpaPak Cardiac Transport System occurred at University of Florida Health (UF Health) and Le Bonheur Children’s Hospital (TN). Starting in Q1 2019, Paragonix SherpaPak™ CTS have been shipped with heart connectors covering most aortic diameters, permitting the anchoring of variously sized hearts, including small pediatric hearts, to its proprietary suspension system for improved donor heart transport.
Paragonix Technologies, Inc. Announces FDA Clearance and U.S. Launch of the Paragonix SherpaPak™ Pancreas Transport System
Paragonix Technologies, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Paragonix SherpaPak™ Pancreas Transport System (PTS). Starting immediately, the Paragonix SherpaPak™ PTS will be commercially available to pancreas transplant centers and Organ Procurement Organizations. The Paragonix SherpaPak PTS provides unprecedented thermal and physical protection to the donor pancreas during transport from donor to recipient patients.
Surgeons at Duke University Hospital Use Advanced Preservation and Transportation System to Safeguard Donor Heart During Journey Between Donor and Recipient
DURHAM, N.C.–(BUSINESS WIRE)-Duke University Hospital has transported its first donor heart using the only commercially available FDA cleared and CE marked system for cold donor heart storage and transport. The Paragonix SherpaPak™ Cardiac Transport System (CTS) was used in a clinical case to safeguard a donor heart prior to it
Paragonix Technologies is happy to announce that we will be sponsoring pet therapy at the University of Florida! Pet therapy can go a long way to help patients feel like themselves again, and we are proud to give back to patients. Meet the Paragonix pets! Paragonix Technologies is proud to
Paragonix Technologies is excited to announce that we will be sponsoring a program to train fellows in the use of the Paragonix SherpaPak™ Cardiac Transport System. Fellows will be educated on Paragonix’s SherpaPak Primary Graph Dysfunction Cardiac Transport System, which has been adapted by multiple transplant programs around the world. They can